In This Photo The Logo Of Meta Ai Is Dis

Mark Zuckerberg Poaches Sam Altman’s Talent With Multimillion-Dollar Offers To Build Meta’s AI Team

Meta Platforms Inc. (NASDAQ:META), under the leadership of CEO Mark Zuckerberg, is on a relentless pursuit for artificial intelligence (AI) specialists, with remuneration packages that outstrip those of professional sports stars and Fortune 500 CEOs.What Happened: As per a report, Meta’s recruitment drive is focused on assembling an elite AI team for its Superintelligence Labs. […]

Read More
Primo Brands Water Truck

Primo Brands Coverage Initiated: Analyst Sees EBITDA Gains From Cost Cuts, Bottled Water Momentum

BofA Securities analyst Peter T. Galbo initiated coverage on Primo Brands Corporation (NYSE:PRMB), with a price forecast of $42.Galbo notes that Primo Brands stock is expected to appreciate over the next 12 months as the company realizes cost synergies, targeting $300 million in EBITDA by 2026.If valuation multiples stay steady, this should support growth in […]

Read More
Nvidia Investment

NVIDIA Q1 Earnings Preview: Analyst Cautions On Macro Uncertainty, China Restrictions – ‘Stay Long The Stock’

All eyes turn to NVIDIA Corporation (NASDAQ:NVDA) and the company’s AI dominance, new products and questions for the China market when the company reports first-quarter financial results Wednesday after market close.Here are the analyst earnings estimates, what experts are saying ahead of the report and key items to watch.Earnings Estimates: Analysts expect Nvidia to report […]

Read More
A 3d Illustration Depicting Cancer Cells

Guardant Health, Pfizer Collaborate To Develop New Cancer Therapies Using Liquid Biopsy Platform

Guardant Health, Inc. (NASDAQ:GH) on Thursday announced a strategic collaboration with Pfizer, Inc. (NYSE:PFE) to support the development and commercialization of Pfizer’s oncology portfolio using the Guardant Infinity smart liquid biopsy platform.Under the multi-year collaboration agreement, Guardant and Pfizer aim to:Utilize Guardant’s portfolio of liquid biopsy tests in Pfizer’s global clinical studies.Evaluate the clinical utility […]

Read More
What Happened 0

Mark Cuban Advises Against Sole Dependence on AI for Work, Says It’s ‘Never the Answer’

Mark Cuban warned Friday about the dangers of over-reliance on artificial intelligence in the workplace.What Happened: Cuban emphasized that AI should be utilized as a tool to augment existing skills, rather than replacing them.Cuban, while participating in a SXSW panel discussion on Friday, underscored the significance of AI in the current professional environment. However, he […]

Read More
Genetic Research And Biotech Science Con

Ultragenyx Is Uniquely Positioned In Long Term, Remains On JPMorgan’s Focus List

JPMorgan on Thursday shared updated thoughts on Ultragenyx Pharmaceutical Inc’s (NASDAQ:RARE) setrusumab program in osteogenesis imperfecta (OI).In a fourth-quarter 2024 press release, the company said patients continue dosing in the Phase 3 Orbit and Cosmic trials, which evaluate setrusumab in pediatric and young adult patients with OI.The randomized, placebo-controlled Phase 3 portion of the Orbit […]

Read More